Drug Profile
RG 7203
Alternative Names: RG7203Latest Information Update: 29 Jul 2015
Price :
$50
*
At a glance
- Originator Roche
- Class Antipsychotics; Small molecules
- Mechanism of Action Phosphodiesterase 10A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 29 Jul 2015 Discontinued - Phase-I for Schizophrenia in Switzerland (unspecified route)
- 16 Oct 2014 Roche completes a phase I trial in Schizophrenia in Switzerland
- 15 Oct 2014 Roche initiates enrolment a phase I trial for Schizophrenia in Switzerland before October 2014